Elon Musk's Brother Kimbal Welcomes "Any and All Competitors"
Kimbal Musk is on a mission to bring gardens and nutritious food to kids and families across the country.
The CEO and co-founder of the recently-renamed non-profit Big Green announced Detroit will be the next city to have 100 Learning Gardens. These urban gardens set up in schools require only 6 to 7 employees to monitor an entire city.
Musk explains, “At Big Green we really have perfected the model of doing Learning Gardens at scale.”
Detroit is the first step in Musk achieving his goal to bring 1,000 new Learning Gardens to cities across the country by 2020. The effort should cost a total of $25 million.
Musk, the younger brother of Tesla and SpaceX CEO Elon, encourages competition for Big Green.
“Competitors mean more impact...and we need all the help we can get."
The impact has been significant across the Learning Garden cities. Musk says he regularly receives emails from the parents of students. After students go home and demand kale for dinner, those parents email Musk asking what kale is. For Musk, this is the greatest example of education starting with kids and impacting whole families and communities.
For the full interview, [click here](https://cheddar.com/videos/kimbal-musks-big-non-profit-announcement).
JetBlue officials say a plane rocked back with its nose pointed skyward after landing at New York's John F. Kennedy International Airport because of a shift in weight on the aircraft.
Big Business This Week is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street. This week we highlight Rivian, Costco, Nokia, Wyndham Hotels & Resorts, Choice Hotels and Rite Aid
Spirit Airlines canceled about 100 flights on Friday after pulling some planes out of service for inspections, and the airline expects the disruptions to last several days.
CVS Health is pulling from its shelves some cough-and-cold treatments that contain an ingredient that has been deemed ineffective by doctors and researchers.
